ALC vs. BMY: A Head-to-Head Stock Comparison
Updated onHere’s a clear look at ALC and BMY, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Profile
Symbol | ALC | BMY |
---|---|---|
Company Name | Alcon Inc. | Bristol-Myers Squibb Company |
Country | Switzerland | United States |
GICS Sector | Health Care | Health Care |
GICS Industry | Health Care Equipment & Supplies | Pharmaceuticals |
Market Capitalization | 40.08 billion USD | 98.23 billion USD |
Exchange | NYSE | NYSE |
Listing Date | April 9, 2019 | June 1, 1972 |
Security Type | Common Stock | Common Stock |
Historical Performance
This chart compares the performance of ALC and BMY by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.
Historical Performance at a Glance
Symbol | ALC | BMY |
---|---|---|
5-Day Price Return | 3.28% | 0.94% |
13-Week Price Return | -1.04% | 2.20% |
26-Week Price Return | -11.43% | -13.78% |
52-Week Price Return | 0.56% | -2.11% |
Month-to-Date Return | 0.75% | 11.43% |
Year-to-Date Return | -5.90% | -14.67% |
10-Day Avg. Volume | 0.92M | 9.83M |
3-Month Avg. Volume | 1.06M | 14.15M |
3-Month Volatility | 21.77% | 26.02% |
Beta | 1.01 | 0.34 |
Profitability
Return on Equity (TTM)
ALC
5.22%
Health Care Equipment & Supplies Industry
- Max
- 34.53%
- Q3
- 19.38%
- Median
- 9.52%
- Q1
- 4.86%
- Min
- -7.58%
ALC’s Return on Equity of 5.22% is on par with the norm for the Health Care Equipment & Supplies industry, indicating its profitability relative to shareholder equity is typical for the sector.
BMY
29.57%
Pharmaceuticals Industry
- Max
- 38.59%
- Q3
- 19.84%
- Median
- 11.90%
- Q1
- 5.63%
- Min
- -9.96%
In the upper quartile for the Pharmaceuticals industry, BMY’s Return on Equity of 29.57% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.
Net Profit Margin (TTM)
ALC
11.28%
Health Care Equipment & Supplies Industry
- Max
- 23.34%
- Q3
- 13.06%
- Median
- 9.53%
- Q1
- 5.96%
- Min
- -3.87%
ALC’s Net Profit Margin of 11.28% is aligned with the median group of its peers in the Health Care Equipment & Supplies industry. This indicates its ability to convert revenue into profit is typical for the sector.
BMY
10.59%
Pharmaceuticals Industry
- Max
- 34.51%
- Q3
- 17.73%
- Median
- 12.12%
- Q1
- 5.99%
- Min
- -7.73%
BMY’s Net Profit Margin of 10.59% is aligned with the median group of its peers in the Pharmaceuticals industry. This indicates its ability to convert revenue into profit is typical for the sector.
Operating Profit Margin (TTM)
ALC
15.24%
Health Care Equipment & Supplies Industry
- Max
- 29.44%
- Q3
- 17.80%
- Median
- 13.95%
- Q1
- 8.73%
- Min
- -3.56%
ALC’s Operating Profit Margin of 15.24% is around the midpoint for the Health Care Equipment & Supplies industry, indicating that its efficiency in managing core business operations is typical for the sector.
BMY
17.82%
Pharmaceuticals Industry
- Max
- 41.53%
- Q3
- 23.00%
- Median
- 16.24%
- Q1
- 9.24%
- Min
- -6.94%
BMY’s Operating Profit Margin of 17.82% is around the midpoint for the Pharmaceuticals industry, indicating that its efficiency in managing core business operations is typical for the sector.
Profitability at a Glance
Symbol | ALC | BMY |
---|---|---|
Return on Equity (TTM) | 5.22% | 29.57% |
Return on Assets (TTM) | 3.69% | 5.41% |
Net Profit Margin (TTM) | 11.28% | 10.59% |
Operating Profit Margin (TTM) | 15.24% | 17.82% |
Gross Profit Margin (TTM) | 54.25% | 73.92% |
Financial Strength
Current Ratio (MRQ)
ALC
2.70
Health Care Equipment & Supplies Industry
- Max
- 4.90
- Q3
- 3.05
- Median
- 2.14
- Q1
- 1.49
- Min
- 0.86
ALC’s Current Ratio of 2.70 aligns with the median group of the Health Care Equipment & Supplies industry, indicating that its short-term liquidity is in line with its sector peers.
BMY
1.21
Pharmaceuticals Industry
- Max
- 4.49
- Q3
- 2.77
- Median
- 1.74
- Q1
- 1.26
- Min
- 0.11
BMY’s Current Ratio of 1.21 falls into the lower quartile for the Pharmaceuticals industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.
Debt-to-Equity Ratio (MRQ)
ALC
0.24
Health Care Equipment & Supplies Industry
- Max
- 1.49
- Q3
- 0.71
- Median
- 0.45
- Q1
- 0.14
- Min
- 0.00
ALC’s Debt-to-Equity Ratio of 0.24 is typical for the Health Care Equipment & Supplies industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
BMY
2.82
Pharmaceuticals Industry
- Max
- 2.44
- Q3
- 1.07
- Median
- 0.42
- Q1
- 0.11
- Min
- 0.00
With a Debt-to-Equity Ratio of 2.82, BMY operates with exceptionally high leverage compared to the Pharmaceuticals industry norm. This suggests an aggressive reliance on debt financing, which can magnify returns but also significantly elevates financial risk.
Interest Coverage Ratio (TTM)
ALC
9.60
Health Care Equipment & Supplies Industry
- Max
- 58.29
- Q3
- 25.56
- Median
- 9.06
- Q1
- 3.60
- Min
- -28.92
ALC’s Interest Coverage Ratio of 9.60 is positioned comfortably within the norm for the Health Care Equipment & Supplies industry, indicating a standard and healthy capacity to cover its interest payments.
BMY
-4.77
Pharmaceuticals Industry
- Max
- 103.95
- Q3
- 44.18
- Median
- 9.83
- Q1
- 2.82
- Min
- -42.71
BMY has a negative Interest Coverage Ratio of -4.77. This indicates that its earnings were insufficient to cover even its operational costs, let alone its interest payments, signaling significant financial distress.
Financial Strength at a Glance
Symbol | ALC | BMY |
---|---|---|
Current Ratio (MRQ) | 2.70 | 1.21 |
Quick Ratio (MRQ) | 1.66 | 1.11 |
Debt-to-Equity Ratio (MRQ) | 0.24 | 2.82 |
Interest Coverage Ratio (TTM) | 9.60 | -4.77 |
Growth
Revenue Growth
EPS Growth
Dividend
Dividend Yield (TTM)
ALC
0.29%
Health Care Equipment & Supplies Industry
- Max
- 4.05%
- Q3
- 1.76%
- Median
- 0.71%
- Q1
- 0.00%
- Min
- 0.00%
ALC’s Dividend Yield of 0.29% is consistent with its peers in the Health Care Equipment & Supplies industry, providing a dividend return that is standard for its sector.
BMY
5.02%
Pharmaceuticals Industry
- Max
- 6.98%
- Q3
- 3.32%
- Median
- 2.13%
- Q1
- 0.14%
- Min
- 0.00%
With a Dividend Yield of 5.02%, BMY offers a more attractive income stream than most of its peers in the Pharmaceuticals industry, signaling a strong commitment to shareholder returns.
Dividend Payout Ratio (TTM)
ALC
58.30%
Health Care Equipment & Supplies Industry
- Max
- 160.00%
- Q3
- 72.47%
- Median
- 27.49%
- Q1
- 0.00%
- Min
- 0.00%
ALC’s Dividend Payout Ratio of 58.30% is within the typical range for the Health Care Equipment & Supplies industry, suggesting a balanced approach between shareholder payouts and company reinvestment.
BMY
98.10%
Pharmaceuticals Industry
- Max
- 165.20%
- Q3
- 90.59%
- Median
- 49.13%
- Q1
- 28.91%
- Min
- 0.00%
BMY’s Dividend Payout Ratio of 98.10% is in the upper quartile for the Pharmaceuticals industry. This indicates a strong commitment to shareholder returns but also suggests that a smaller portion of earnings is retained for reinvestment compared to many peers.
Dividend at a Glance
Symbol | ALC | BMY |
---|---|---|
Dividend Yield (TTM) | 0.29% | 5.02% |
Dividend Payout Ratio (TTM) | 58.30% | 98.10% |
Valuation
Price-to-Earnings Ratio (TTM)
ALC
40.00
Health Care Equipment & Supplies Industry
- Max
- 73.48
- Q3
- 51.69
- Median
- 34.31
- Q1
- 25.74
- Min
- 11.47
ALC’s P/E Ratio of 40.00 is within the middle range for the Health Care Equipment & Supplies industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
BMY
19.55
Pharmaceuticals Industry
- Max
- 42.51
- Q3
- 26.88
- Median
- 19.11
- Q1
- 15.12
- Min
- 0.00
BMY’s P/E Ratio of 19.55 is within the middle range for the Pharmaceuticals industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
Price-to-Sales Ratio (TTM)
ALC
4.51
Health Care Equipment & Supplies Industry
- Max
- 9.53
- Q3
- 5.26
- Median
- 3.39
- Q1
- 2.13
- Min
- 0.00
ALC’s P/S Ratio of 4.51 aligns with the market consensus for the Health Care Equipment & Supplies industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
BMY
2.07
Pharmaceuticals Industry
- Max
- 7.55
- Q3
- 4.54
- Median
- 2.11
- Q1
- 1.52
- Min
- 0.00
BMY’s P/S Ratio of 2.07 aligns with the market consensus for the Pharmaceuticals industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
Price-to-Book Ratio (MRQ)
ALC
2.34
Health Care Equipment & Supplies Industry
- Max
- 10.85
- Q3
- 5.98
- Median
- 3.48
- Q1
- 2.43
- Min
- 0.69
ALC’s P/B Ratio of 2.34 is in the lower quartile for the Health Care Equipment & Supplies industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.
BMY
5.40
Pharmaceuticals Industry
- Max
- 9.78
- Q3
- 4.96
- Median
- 2.23
- Q1
- 1.46
- Min
- 0.60
BMY’s P/B Ratio of 5.40 is in the upper tier for the Pharmaceuticals industry. This indicates that investors are paying a premium relative to the company’s net assets, a valuation that hinges on its ability to generate superior profits.
Valuation at a Glance
Symbol | ALC | BMY |
---|---|---|
Price-to-Earnings Ratio (TTM) | 40.00 | 19.55 |
Price-to-Sales Ratio (TTM) | 4.51 | 2.07 |
Price-to-Book Ratio (MRQ) | 2.34 | 5.40 |
Price-to-Free Cash Flow Ratio (TTM) | 30.83 | 6.77 |